Dias Da Costa, MarianaLeal Rato, MiguelCruz, DianaValadas, AnabelaAntunes, Ana PatríciaAlbuquerque, Luísa2022-01-042022-01-042021J Neuroimmunol. 2021 Dec 15;361:5777390165-5728http://hdl.handle.net/10451/50690© 2021 Elsevier B.V. All rights reserved.We report the case of a patient with symptoms of myelopathy following acute SARS-CoV-2 infection. MRI documented a longitudinally extensive transverse myelitis and further investigation was unremarkable with the exception of positivity for MOG-IgG in serum. This report extends the spectrum of post-COVID-19 neurological syndromes, and documents a very significant improvement to long-term oral corticosteroid therapy in this setting. Further prospective studies are needed to establish the risk of recurrence in this subset of patients.engCOVID-19MOG-IgGMyelitisPost-infectious myelitisSARS-CoV-2journal article10.1016/j.jneuroim.2021.5777391872-8421